| Theresa Dolan, APN | |
|
1441 Branding Ave Ste 310, Downers Grove, IL 60515-5624 | |
| (630) 829-1038 | |
| (630) 829-1080 |
| Full Name | Theresa Dolan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1441 Branding Ave Ste 310, Downers Grove, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003294620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 209.012794 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
Obesity has long been associated with increased risk of colorectal cancer, but the link has never been understood. Now, a research team led by investigators at Thomas Jefferson University has revealed the biological connection, and in the process, has identified an approved drug that might prevent development of the cancer.
News outlets report that this little-noticed provision puts in place stricter limits regarding the amount companies can deduct from their federal tax bills. Also in the news, The Associated Press reports on ways health plans discourage sick people from enrolling and The New York Times examines the health law's efforts to expand mental health coverage.
The German Federal Institute for Drugs and Medical Devices (BfArM) has granted Moberg Derma approval to initiate a clinical phase II trial for Limtop. The aim is to evaluate the efficacy and safety of three different dose regimens of Limtop in a study involving 96 patients with Actinic Keratosis (AK) on the head or face.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
› Verified 5 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
Obesity has long been associated with increased risk of colorectal cancer, but the link has never been understood. Now, a research team led by investigators at Thomas Jefferson University has revealed the biological connection, and in the process, has identified an approved drug that might prevent development of the cancer.
News outlets report that this little-noticed provision puts in place stricter limits regarding the amount companies can deduct from their federal tax bills. Also in the news, The Associated Press reports on ways health plans discourage sick people from enrolling and The New York Times examines the health law's efforts to expand mental health coverage.
The German Federal Institute for Drugs and Medical Devices (BfArM) has granted Moberg Derma approval to initiate a clinical phase II trial for Limtop. The aim is to evaluate the efficacy and safety of three different dose regimens of Limtop in a study involving 96 patients with Actinic Keratosis (AK) on the head or face.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
› Verified 5 days ago
| Entity Name | Sandeep Chandra Md Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407897218 PECOS PAC ID: 7719934611 Enrollment ID: O20050404000162 |
News Archive
Obesity has long been associated with increased risk of colorectal cancer, but the link has never been understood. Now, a research team led by investigators at Thomas Jefferson University has revealed the biological connection, and in the process, has identified an approved drug that might prevent development of the cancer.
News outlets report that this little-noticed provision puts in place stricter limits regarding the amount companies can deduct from their federal tax bills. Also in the news, The Associated Press reports on ways health plans discourage sick people from enrolling and The New York Times examines the health law's efforts to expand mental health coverage.
The German Federal Institute for Drugs and Medical Devices (BfArM) has granted Moberg Derma approval to initiate a clinical phase II trial for Limtop. The aim is to evaluate the efficacy and safety of three different dose regimens of Limtop in a study involving 96 patients with Actinic Keratosis (AK) on the head or face.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theresa Dolan, APN 29373 Network Pl, Chicago, IL 60673-1293 Ph: (847) 390-5900 | Theresa Dolan, APN 1441 Branding Ave Ste 310, Downers Grove, IL 60515-5624 Ph: (630) 829-1038 |
News Archive
Obesity has long been associated with increased risk of colorectal cancer, but the link has never been understood. Now, a research team led by investigators at Thomas Jefferson University has revealed the biological connection, and in the process, has identified an approved drug that might prevent development of the cancer.
News outlets report that this little-noticed provision puts in place stricter limits regarding the amount companies can deduct from their federal tax bills. Also in the news, The Associated Press reports on ways health plans discourage sick people from enrolling and The New York Times examines the health law's efforts to expand mental health coverage.
The German Federal Institute for Drugs and Medical Devices (BfArM) has granted Moberg Derma approval to initiate a clinical phase II trial for Limtop. The aim is to evaluate the efficacy and safety of three different dose regimens of Limtop in a study involving 96 patients with Actinic Keratosis (AK) on the head or face.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
› Verified 5 days ago
Mrs. Tamyra Michelle Janicki, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1315 Butterfield Rd Ste 206, Downers Grove, IL 60515 Phone: 630-317-7690 Fax: 630-317-7894 | |
Mrs. Ebonique Thomson, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3005 Highland Pkwy, Downers Grove, IL 60515 Phone: 716-249-1820 | |
Mansi P Patel, ACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1441 Branding Ave, Ste 310, Downers Grove, IL 60515 Phone: 312-609-0300 | |
Ms. Elizabeth Sowa, MSN, ANP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1441 Branding Ave Ste 310, Downers Grove, IL 60515 Phone: 630-829-1084 | |
Letasha Lewis, MSN, FNP-C Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 900 Ogden Ave # 335, Downers Grove, IL 60515 Phone: 773-234-0388 Fax: 773-234-0394 | |
Lizeht Monarrez, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1441 Branding Ave Ste 310, Downers Grove, IL 60515 Phone: 630-829-1084 |